| 000 | 01343 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514001103.0 | ||
| 264 | 0 | _c20010628 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0379-5284 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAl-Wahadneh, A M | |
| 245 | 0 | 0 |
_aAdverse reactions of intravenous immunoglobulin. _h[electronic resource] |
| 260 |
_bSaudi medical journal _cOct 2000 |
||
| 300 |
_a953-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcademic Medical Centers |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCross Infection _xetiology |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xclassification |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadverse effects |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xdrug therapy |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aInfection Control _xmethods |
| 650 | 0 | 4 | _aJordan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPrimary Prevention _xmethods |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aKhriesat, I A | |
| 700 | 1 | _aKuda, E H | |
| 773 | 0 |
_tSaudi medical journal _gvol. 21 _gno. 10 _gp. 953-6 |
|
| 999 |
_c11301870 _d11301870 |
||